Global pharmaceutical company Cadila Healthcare on Friday posted a 11 percent increase in its net profit at Rs 388.7 crore for the fourth quarter ended March as compared to Rs.350.4 crore in the year-ago period, on account of robust sales.
Total income rose seven percent to Rs.2,449 crore in the quarter under review from Rs.2,288 crore in the corresponding period last year, it said in a filing at Bombay Stock Exchange (BSE).
The company said its formulation business in India grew by 11 percent during last fiscal on the back of launch of more than 40 new products, including line extensions, while in emerging markets, it grew 17 percent.
For 2015-16, the medicine maker reported a 32 percent rise in its net profit at Rs.1,523 crore from Rs.1,151 crore in 2014-15.
Its formulation business in the US was the largest contributor to the consolidated revenues, growing 19 percent.
Company's scrip on Friday closed at Rs.326.55, down 2.05 percent on BSE from previous close.
--IANS
bdc/vd
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
